WHO ICTRP trial
To evaluate the characteristic changes of sevoflurane, propofol and esketamine…
ChiCTR2300075108 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300075108 |
|---|---|
| Public title | To evaluate the characteristic changes of sevoflurane, propofol and esketamine induced unconscious EEG in diabetes patients and non-diabetes patients |
| Scientific title | To evaluate the characteristic changes of sevoflurane, propofol and esketamine induced unconscious EEG in diabetes patients and non-diabetes patients |
| Primary sponsor | Peking University Third Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | diabetes mellitus |
| Interventions | Group Propofol(T2DM patients):Propofol anesthesia induction;Group Propofol(Healthy patients):Propofol anesthesia induction;Group H-Sevoflurane(T2DM patients):Sevoflurane anesthesia induction;Group H-Sevoflurane(Healthy patients):Sevoflurane… |
| Registration date | Aug 25, 2023 |
| Target size | Group Propofol(T2DM patients):20;Group Propofol(Healthy patients):20;Group… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: